BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 32814943)

  • 1. Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management.
    Daley CL; Winthrop KL
    J Infect Dis; 2020 Aug; 222(Suppl 4):S199-S211. PubMed ID: 32814943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ; Wu TS; Chiang PC; Lee MH
    J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y; Tsuyuguchi K; Kobayashi T; Kurahara Y; Yoshida S; Kagawa T; Hayashi S; Suzuki K
    J Infect Chemother; 2020 Jul; 26(7):676-680. PubMed ID: 32171660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.
    Wallace RJ; Brown-Elliott BA; McNulty S; Philley JV; Killingley J; Wilson RW; York DS; Shepherd S; Griffith DE
    Chest; 2014 Aug; 146(2):276-282. PubMed ID: 24457542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure.
    Griffith DE; Thomson R; Flume PA; Aksamit TR; Field SK; Addrizzo-Harris DJ; Morimoto K; Hoefsloot W; Mange KC; Yuen DW; Ciesielska M; Wallace RJ; van Ingen J; Brown-Elliott BA; Coulter C; Winthrop KL;
    Chest; 2021 Sep; 160(3):831-842. PubMed ID: 33887244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.
    Ramirez J; Mason C; Ali J; Lopez FA
    J La State Med Soc; 2008; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by
    Griffith DE; Eagle G; Thomson R; Aksamit TR; Hasegawa N; Morimoto K; Addrizzo-Harris DJ; O'Donnell AE; Marras TK; Flume PA; Loebinger MR; Morgan L; Codecasa LR; Hill AT; Ruoss SJ; Yim JJ; Ringshausen FC; Field SK; Philley JV; Wallace RJ; van Ingen J; Coulter C; Nezamis J; Winthrop KL;
    Am J Respir Crit Care Med; 2018 Dec; 198(12):1559-1569. PubMed ID: 30216086
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K
    BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease.
    Kim HJ; Lee JS; Kwak N; Cho J; Lee CH; Han SK; Yim JJ
    BMC Pulm Med; 2019 Nov; 19(1):212. PubMed ID: 31711459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines.
    Ku JH; Henkle E; Carlson KF; Marino M; Brode SK; Marras TK; Winthrop KL
    Clin Infect Dis; 2023 Feb; 76(3):e1408-e1415. PubMed ID: 35607719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease.
    Tanaka E; Amitani R; Niimi A; Suzuki K; Murayama T; Kuze F
    Am J Respir Crit Care Med; 1997 Jun; 155(6):2041-6. PubMed ID: 9196113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of recurrence after successful treatment of Mycobacterium avium complex lung disease.
    Min J; Park J; Lee YJ; Kim SJ; Park JS; Cho YJ; Yoon HI; Lee CT; Lee JH
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1239-45. PubMed ID: 26459540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use.
    Hoy SM
    Clin Drug Investig; 2021 Apr; 41(4):405-412. PubMed ID: 33723805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of bronchial lavage for the diagnosis of pulmonary disease caused by Mycobacterium avium-intracellulare complex (MAC) infection.
    Sugihara E; Hirota N; Niizeki T; Tanaka R; Nagafuchi M; Koyanagi T; Ono N; Rikimaru T; Aizawa H
    J Infect Chemother; 2003 Dec; 9(4):328-32. PubMed ID: 14691654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease.
    Maekura R; Miki K; Tateishi Y; Matsumoto S; Kitada S; Miki M; Kida H
    Microbiol Spectr; 2022 Jun; 10(3):e0053022. PubMed ID: 35467367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy.
    Koyama K; Ohshima N; Kawashima M; Okuda K; Sato R; Nagai H; Matsui H; Ohta K
    Respir Med; 2015 Oct; 109(10):1347-53. PubMed ID: 26365483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Mycobacterium avium Complex (MAC).
    Griffith DE
    Semin Respir Crit Care Med; 2018 Jun; 39(3):351-361. PubMed ID: 30071550
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors for clinical progression in patients with pulmonary Mycobacterium avium complex disease without culture-positive sputum: a single-center, retrospective study.
    Nonaka M; Matsuyama M; Sakai C; Matsumura S; Arai N; Nakajima M; Saito T; Hizawa N
    Eur J Med Res; 2023 Jun; 28(1):186. PubMed ID: 37291649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease by Single Bacterial Isolation Plus Anti-GPL-Core IgA Antibody.
    Kawasaki T; Kitada S; Fukushima K; Akiba E; Haduki K; Saito H; Nitta T; Kawano A; Miyazaki A; Nii T; Kuge T; Koba T; Matsuki T; Tsujino K; Miki K; Maekura R; Kida H
    Microbiol Spectr; 2022 Feb; 10(1):e0140621. PubMed ID: 34985326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease.
    Fukushima K; Kitada S; Komukai S; Kuge T; Matsuki T; Kagawa H; Tsujino K; Miki M; Miki K; Kida H
    Sci Rep; 2021 Jan; 11(1):1178. PubMed ID: 33441977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.